Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in CRVS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,109,297
+$356,970 QoQ
Shares Held
208,119
+10.6% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 172 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. CRVS ranks #165 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRVS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,109,297 208,119
2026-03-31 $2,752,327 188,129
2025-12-31 $1,318,032 171,173
2025-09-30 $1,310,297 177,788
2025-06-30 $647,284 161,821
2024-12-31 $160,328 29,968
2024-09-30 $82,727 15,668
2024-06-30 $28,515 15,668
2024-03-31 $27,889 15,668
2023-12-31 $27,575 15,668
2023-09-30 $22,875 15,668
2023-06-30 $35,879 15,668
2021-12-31 $27,032 11,217
2021-09-30 $54,290 11,217
2021-03-31 $42,596 13,830